PHF2 and hepatocellular carcinoma: Because excess PA may be metabolized into palmitoyl-coenzyme A (CoA) and then transferred to the cysteine residue of target proteins by ZDHHC-mediated S-palmitoylation, we checked whether PA treatment increased palmitoyl-CoA and PHF2 palmitoylation in HCC cells.